Azulfidine and Post procedural complication - a phase IV clinical study of FDA data

Summary:

Post procedural complication is reported as a side effect among people who take Azulfidine (sulfasalazine), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Enbrel, and have Psoriasis.

The phase IV clinical study analyzes which people have Post procedural complication when taking Azulfidine. It is created by eHealthMe based on reports of 7,893 people who have side effects when taking Azulfidine from the FDA, and is updated regularly.

What is Azulfidine?

Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,997 Azulfidine users. Check the latest studies of Azulfidine.

What is Post procedural complication?

Post procedural complication is found to be associated with 1,089 drugs and 1,362 conditions by eHealthMe. Check the latest studies of Post procedural complication.

On Jul, 17, 2026

7,893 people reported to have side effects when taking Azulfidine.
Among them, 18 people (0.23%) have Post procedural complication.

Could Azulfidine cause Post procedural complication?

Among these 18 people:

How long have people been on Azulfidine when they have Post procedural complication? *

What is the gender of people who have Post procedural complication when taking Azulfidine? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Post procedural complication when taking Azulfidine? *

What are other drugs people take besides Azulfidine? *

What are other side effects people have besides Post procedural complication? *

Chest Pain: 8 people, 44.44%
Abdominal Pain Upper: 7 people, 38.89%
Anaemia (lack of blood): 7 people, 38.89%
Cellulitis (infection under the skin): 6 people, 33.33%
Kidney Stones: 6 people, 33.33%
Heart Attack: 5 people, 27.78%
Feeling Abnormal: 5 people, 27.78%
Coronary Artery Restenosis (recurrence of narrowing of artery): 5 people, 27.78%
Coronary Artery Stenosis (narrowing of coronary artery): 5 people, 27.78%
Dizziness Postural: 5 people, 27.78%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 7 people, 38.89%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 11.11%
Joint Pain: 2 people, 11.11%
High Blood Pressure: 2 people, 11.11%
Cardiac Failure Congestive: 2 people, 11.11%
Renal Impairment (severely reduced kidney function): 1 person, 5.56%
Osteoporosis (bones weak and more likely to break): 1 person, 5.56%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 5.56%
Insomnia (sleeplessness): 1 person, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Azulfidine and have Post procedural complication?

- Check whether Post procedural complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azulfidine:

Azulfidine (7,997 reports)

Browse all side effects of Azulfidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural complication:

Post procedural complication (1,089 drugs)

Browse all the conditions that are associated with Post procedural complication:

Post procedural complication (1,362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Azulfidine) and Azulfidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.